Anti-IgE treatment in allergic rhinitis.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of pediatric otorhinolaryngology"
DOI: 10.1016/j.ijporl.2019.109674
Abstract: OBJECTIVES To review the efficacy of anti-IgE therapy in allergic rhinitis (AR). METHODS Literature search was performed using the PubMed and Proquest Central databases at Kırıkkale University Library. RESULTS Although the skin prick testing in… read more here.
Keywords: allergic rhinitis; ige; mast cells; omalizumab ... See more keywords
Development and validation of a new IgE-Tolerant ELISA method for quantifying serum concentration of omalizumab.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of pharmaceutical and biomedical analysis"
DOI: 10.1016/j.jpba.2020.113120
Abstract: BACKGROUND Omalizumab is effectively used in asthma therapy, but ELISA methods used for omalizumab determination in blood from asthma patients may be interfered by the pre-existing IgE. OBJECTIVE To reduce the effect of pre-existing IgE… read more here.
Keywords: tolerant elisa; omalizumab; ige tolerant; method ... See more keywords
Indirect comparison of bronchial thermoplasty versus omalizumab for uncontrolled severe asthma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Asthma"
DOI: 10.1080/02770903.2017.1337789
Abstract: ABSTRACT Objective: Bronchial thermoplasty (BT) as an add-on therapy for uncontrolled severe asthma is an alternative to biologic therapies like omalizumab (OM). We conducted an indirect treatment comparison (ITC) to appraise comparative effectiveness of BT… read more here.
Keywords: omalizumab; treatment; severe asthma; uncontrolled severe ... See more keywords
Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Asthma"
DOI: 10.1080/02770903.2018.1541357
Abstract: Abstract Background: The anti-immunoglobulin E monoclonal antibody, omalizumab, is used to treat severe asthma and has the potential to ameliorate airway inflammation. However, the effect of omalizumab in ameliorating upper airway inflammation has not been… read more here.
Keywords: response; omalizumab; severe asthma; inflammation ... See more keywords
Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma"
DOI: 10.1080/02770903.2022.2103427
Abstract: Abstract Introduction Humanized monoclonal anti-IgE antibody (omalizumab) has demonstrated efficacy in severe atopic asthma. However, few studies have assessed its efficacy in non-atopic and even less in T2-low severe asthma. The objective was to determinate… read more here.
Keywords: asthma; atopic; non atopic; atopic asthma ... See more keywords
The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2021.1962282
Abstract: ABSTRACT Introduction: Chronic rhinosinusitis with nasal polyposis (CRSwNP) poses a significant healthcare challenge, with diminished quality of life for patients and high costs and resource utilization for disease management. The understanding of CRSwNP pathophysiology has… read more here.
Keywords: rhinosinusitis nasal; nasal polyposis; omalizumab; treatment ... See more keywords
Successful treatment of urticarial vasculitis with omalizumab in children: a case series.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad192
Abstract: Urticarial vasculitis (UV) is a small vessel leukocytoclastic vasculitis, which often needs to be distinguished from urticaria and other dermatoses. Treatment of UV in children is challenging because of the unsatisfying efficacy of antihistamines and… read more here.
Keywords: vasculitis; successful treatment; treatment urticarial; omalizumab ... See more keywords
Efficacy and Safety of Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000912
Abstract: BACKGROUND Omalizumab has been proposed as a possible effective treatment of chronic spontaneous urticaria (CSU). STUDY QUESTION We aimed to access the efficacy and safety of omalizumab in the treatment of CSU based on qualified,… read more here.
Keywords: safety omalizumab; score; chronic spontaneous; omalizumab ... See more keywords
Omalizumab may facilitate drug desensitization in patients failing standard protocols
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.13783
Abstract: subsequent 1 reactions during desensitization trials with rituximab using 12- , 16- and 20- step protocols. desensitization after the first omalizumab dose of 300 mg before 1 week of RDD. 13 Ojaimi et al achieved… read more here.
Keywords: desensitization; may facilitate; omalizumab may; treatment ... See more keywords
Comparison of the Patients with Chronic Urticaria Who Responded and Did Not Respond to Omalizumab Treatment: A Single-Center Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "International Archives of Allergy and Immunology"
DOI: 10.1159/000526205
Abstract: Introduction: Chronic urticaria (CU) is a condition usually lasting longer than 6 weeks, with wheals and angioedema, sometimes both. Omalizumab is a recombinant humanized monoclonal IgG antibody developed against IgE. In some patients with CU,… read more here.
Keywords: omalizumab treatment; response omalizumab; count; treatment ... See more keywords
ABPA relapse after discontinuation of omalizumab
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.2223
Abstract: Allergic bronchopulmonary aspergillosis (ABPA) often complicates severe asthma (SA). Omalizumab (OMA) has been successfully employed in the treatment of ABPA, in addition to systemic corticosteroids and itraconazole. We report two cases of patients with allergic… read more here.
Keywords: abpa relapse; omalizumab; relapse discontinuation; abpa ... See more keywords